Vivo Bio Tech (BOM:511509) ROCE %: 4.66% (As of Mar. 2026)


BOM:511509 Vivo Bio Tech Ltd BOM:511509
68 GF Score
Price ₹23.04
GF Value ₹29.55
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Vivo Bio Tech ROCE %?

Vivo Bio Tech BOM:511509 -1.41% 68 ROCE % is 4.66% as of Mar. 2026. GuruFocus rates BOM:511509 with a GF Score™ of 68/100 and a GF Value™ of ₹29.55 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vivo Bio Tech's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.66%.

Vivo Bio Tech  (BOM:511509) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vivo Bio Tech ROCE % Related Terms

Vivo Bio Tech ROCE % Historical Data

* Premium members only.

The historical data trend for Vivo Bio Tech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech ROCE % Chart

Vivo Bio Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.78 12.44 12.00 15.19 8.09

Vivo Bio Tech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.13 10.34 8.73 8.71 4.66
BOM:511509
68GF Score
Vivo Bio Tech Ltd BOM:511509
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivo Bio Tech ROCE % Calculation

Vivo Bio Tech's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=106.587/( ( (1432.31 - 278.399) + (1784.317 - 302.323) )/ 2 )
=106.587/( (1153.911+1481.994)/ 2 )
=106.587/1317.9525
=8.09 %

Vivo Bio Tech's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=69.1/( ( (0 - 0) + (1784.317 - 302.323) )/ 1 )
=69.1/( ( 0 + 1481.994 )/ 1 )
=69.1/1481.994
=4.66 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.66% mean?
Vivo Bio Tech (BOM:511509) has a ROCE % of 4.66% as of Mar. 2026.
Is Vivo Bio Tech's ROCE % too high?
Vivo Bio Tech's current ROCE % is 4.66%. Overall, Vivo Bio Tech has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's ROCE % compare to VRTX and REGN?
Vivo Bio Tech's ROCE % of 4.66% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Vivo Bio Tech's current ROCE % is 4.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹29.55, compared to a current price of ₹23.04 — trading 22% below its estimated fair value. The current ROCE % is 4.66%. Vivo Bio Tech's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current ROCE % is 4.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?

Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued. The current stock price of ₹23.04 is trading 22% below its estimated GF Value™ of ₹29.55. GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.

Key valuation signals for BOM:511509:

  • ROCE %: 4.66%
  • GF Value™: ₹29.55 vs. price of ₹23.04 (22% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivo Bio Tech Business Description

Address Number 8-2-672/ 5 & 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
68GF Score

Get the complete analysis for BOM:511509

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.04
Price
₹29.55
GF Value